Interestingly, CerS4 knockdown restored these phenotypes in MCF-7/ADR cells, indicating that CerS4 governs the EMT process in breast cancer and that reducing CerS4 expression may contribute to the shift of mesenchymal-like cancer cells toward an epithelial state. This evidence concerns the gene CERS4 and breast cancer.